Scilex Holding Co (SCLX) Form 8-K — May 5, 2026
Scilex Holding Company announced that its subsidiary ACEA Therapeutics has entered into a definitive agreement to sell ACEA Pharma to Phoenix Asia Holdings Limited. The transaction values ACEA Pharma at $1 billion, with ACEA Therapeutics receiving 100 million newly issued shares of Phoenix Asia at $10.00 per share. Upon closing, Phoenix Asia will be renamed ACEA Pharma, Inc. and is expected to list on the Nasdaq.
Key figures
- Deal Value Usd
- 1000000000
- Price Per Share
- 10
- Shares Received By Subsidiary
- 100000000
- Post Transaction Ownership Percent
- 82
Price after filing
1 day: -11.5%7 days: -36.5%30 days: -29.4%
Close on the filing date to close N calendar days later (from $10.73). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.